Letter regarding "Hybrid ABSORB bioresorbable vascular scaffold and drug eluting stent or hybrid BVS-DES percutaneous coronary intervention: Method and rationale for hybrid overlapping PCI"

被引：1
|
作者：
Granata, Francesco [1 ]
Moscarella, Elisabetta [1 ]
Varricchio, Attilio [2 ]
机构：
[1] Univ Naples 2, Monaldi Hosp, Dept Cardiothorac & Resp Sci, Chair Cardiol, I-80131 Naples, Italy
[2] Santa Maria della Pieta Hosp, Dept Cardiol, Lab Intervent Cardiol, Nola, Italy
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 190卷
关键词：
Bioresorbable vascular scaffold; Drug eluting-stent; Overlapping technique;
D O I：
10.1016/j.ijcard.2015.04.157
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：7 / 8
页数：2
相关论文
共 34 条
  • [21] The impact of diabetes on 2 years outcome following percutaneous coronary intervention (PCI) in bare metal stent (BMS) and drug eluting stent (DES) subgroups
    Andron, M.
    Alahmar, A.
    Egred, M.
    Albouini, K.
    Grayson, A. D.
    Shaw, M.
    Palmer, N. D.
    Perry, R. A.
    EUROPEAN HEART JOURNAL, 2007, 28 : 459 - 459
  • [22] Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and of the DEB
    Dillen, Daimy M. M.
    Vlaar, Pieter Jan
    Vermeer, Amy J. E.
    Paradies, Valeria
    van Kuijk, Jan-Peter
    Vink, Maarten A.
    Oemrawsingh, Rohit M.
    Hofma, Sjoerd H.
    Magro, Michael
    Remkes, Wouter S.
    de Smet, Bart J. G. L.
    van Rees, Johannes B.
    Somi, Samer
    Halim, Jonathan
    Zimmermann, Frederik M.
    Wijnbergen, Inge F.
    Tijssen, Jan G. P.
    Tonino, Pim A. L.
    Teeuwen, Koen
    AMERICAN HEART JOURNAL, 2023, 266 : 168 - 175
  • [23] No more metallic cages: An attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel
    Naganuma, Toru
    Latib, Azeem
    Ielasi, Alfonso
    Panoulas, Vasileios F.
    Sato, Katsumasa
    Miyazaki, Tadashi
    Colombo, Antonio
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 172 (03) : 618 - 619
  • [24] Clinical Outcomes at 3 Years of the Absorb Bioresorbable Vascular Scaffold Versus Xience Drug-Eluting Metallic Stent in Patients With or Without Acute Coronary Syndrome: AIDA Trial Substudy
    Tijssen, Ruben
    Kerkmeijer, Laura
    Hofma, Sjoerd H.
    van der Schaaf, Rene
    Weevers, Auke
    Kraak, Robin
    Piek, Jan
    Tijssen, Jan
    de Winter, Robert
    Henriques, Jose P. S.
    Wykrzykowska, Joanna
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B163 - B163
  • [25] Safety and Efficacy of Hybrid Platform Design Sirolimus Eluting Stent System in Percutaneous Coronary Intervention (PCI) in ST Elevation Myocardial Infarction (STEMI) Patients at 1 Year After Treatment
    Fischer, Louie
    Mathew, Anoop
    Punnose, Eapen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (16) : S82 - S82
  • [26] 5-Year Clinical Results of a Randomized Trial Evaluating the Absorb Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in De Novo Native Coronary Artery Lesions: Data From the ABSORB Japan Trial
    Kozuma, Ken
    Kimura, Takeshi
    Tanabe, Kengo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B164 - B164
  • [27] Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease-AIDA trial substudy
    Tijssen, Ruben Y. G.
    van der Schaaf, Rene J.
    Kraak, Robin P.
    Vink, Maarten A.
    Hofma, Sjoerd H.
    Arkenbout, E. Karin
    Weevers, Auke P. J. D.
    Kerkmeijer, Laura S. M.
    Onuma, Yoshinobu
    Serruys, Patrick W.
    Beijk, Marcel A. M.
    Koch, Karel T.
    Baan, Jan, Jr.
    Vis, M. Marije
    Piek, Jan J.
    Tijssen, Jan G. P.
    Henriques, Jose P. S.
    de Winter, Robbert J.
    Wykrzykowska, Joanna J.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 95 (01) : 89 - 96
  • [28] 4-year Clinical Results of a Randomized trial Evaluating the Absorb Bioresorbable Vascular Scaffold vs. Metallic Drug-eluting Stent in de novo Native Coronary Artery Lesions: Data from the ABSORB Japan Trial
    Tanabe, Kengo
    Kozuma, Ken
    Kimura, Takeshi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B128 - B129
  • [29] Absorb Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity Score Matching Comparison The BVS-EXAMINATION Study (Bioresorbable Vascular Scaffold-A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-segment Elevation Myocardial Infarction)
    Brugaletta, Salvatore
    Gori, Tommaso
    Low, Adrian F.
    Tousek, Petr
    Pinar, Eduardo
    Gomez-Lara, Josep
    Scalone, Giancarla
    Schulz, Eberhard
    Chan, Mark Y.
    Kocka, Viktor
    Hurtado, Jose
    Gomez-Hospital, Juan Antoni
    Muenzel, Thomas
    Lee, Chi-Hang
    Cequier, Angel
    Valdes, Mariano
    Widimsky, Petr
    Serruys, Patrick W.
    Sabate, Manel
    JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (01) : 189 - 197
  • [30] Clinical Outcomes At 2 Years of The Absorb Bioresorbable Vascular Scaffold Versus The Xience Drug-eluting Metallic Stent In Patients Presenting With Acute Coronary Syndrome Versus Stable Coronary Disease - Aida Trial Sub-study.
    Tijssen, Ruben Y. G.
    van der Schaaf, Rene J.
    Kraak, Robin P.
    Vink, Maarten A.
    Hofma, Sjoerd H.
    Arkenbout, Karin
    Weevers, Auke P. J. D.
    Kerkmeijer, Laura S. M.
    Serruys, Patrick W.
    Onuma, Yoshinobu
    Beijk, Marcel A. M.
    Koch, Karel T.
    Baan, Jan, Jr.
    Vis, M. Marije
    Piek, Jan J.
    Tijssen, Jan G. P.
    Henriques, Jose P. S.
    de Winter, Robbert J.
    Wykrzykowska, Joanna J.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (04) : S39 - S39
1234